A Patient-Specific Ex Vivo Screening Platform for Personalized Acute Myeloid Leukemia (AML) Therapy

被引：3
|
作者：
Azzam, Diana [1 ,2 ]
Volmar, Claude-Henry [1 ,2 ]
Hassan, Al-Ali [3 ]
Perez, Aymee [4 ]
Watts, Justin M. [4 ]
Vargas, Fernando [4 ]
Elias, Roy [4 ]
Vega, Francisco [5 ,6 ]
Zelent, Arthur [4 ]
Cogle, Christopher R. [7 ]
Wahlestedt, Claes [1 ,2 ]
Swords, Ronan T. [4 ]
机构：
[1] Univ Miami, Ctr Therapeut Innovat, Miami, FL USA
[2] Univ Miami, Dept Psychiat & Behav Sci, Miami, FL USA
[3] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Univ Miami, Miller Sch Med, Dept Pathol & Lab Med, Div Hematopathol,Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[6] Jackson Mem Hosp, Miami, FL 33136 USA
[7] Univ Florida, Div Hematol Oncol, Gainesville, FL USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.1352.1352
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] OUTCOME OF PERSONALIZED THERAPY BASED ON HIGH-THROUGHPUT EX VIVO DRUG SCREENING IN PATIENTS WITH RELAPSED, CHEMOREFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Kontro, M.
    Pemovska, Tea
    Kulesskiy, E.
    Edgren, H.
    Eldfors, S.
    Elonen, E.
    Karjalainen, R.
    Majumder, M.
    Murumagi, A.
    Parsons, A.
    Aittokallio, T.
    Wennerberg, K.
    Kallioniemi, O.
    Porkka, K.
    [J]. HAEMATOLOGICA, 2013, 98 : 19 - 20
  • [2] Establishment of a patient-derived acute myeloid leukemia (AML) ex vivo platform for evaluation of novel therapeutic agents
    Verma, Bhavna
    Tati, Swetha
    Ruggeri, Bruce
    Wesa, Amy
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML)
    Pefani, Eleni
    Panoskaltsis, Nicki
    Mantalaris, Athanasios
    Georgiadis, Michael C.
    Pistikopoulos, Efstratios N.
    [J]. COMPUTERS & CHEMICAL ENGINEERING, 2013, 57 : 187 - 195
  • [4] Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening
    Becker, Pamela S.
    [J]. BLOOD CANCER DISCOVERY, 2023, 4 (06): : 437 - 439
  • [5] Patient-Derived Acute Myeloid Leukemia (AML) Ex Vivo platform for Evaluation of Novel Molecular Targeted Therapeutic Agents
    Verma, Bhavna
    Biel, Nicolett
    Ruggeri, Bruce
    Wesa, Amy
    [J]. BLOOD, 2019, 134
  • [6] Defining Patient-Specific Risk in Acute Myeloid Leukemia
    Ho, Tzu-Chieh
    Becker, Michael W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) : 3857 - 3859
  • [7] Ex Vivo Patient-Specific Validation Of Personalized Therapeutic Designed For Multiple Myeloma
    Doudican, Nicole A.
    Vali, Shireen
    Kapoor, Shweta
    Talawdekar, Anay
    Sultana, Zeba
    Alam, Aftab
    Kumar, Ansu
    Singh, Neeraj Kumar
    Tyagi, Anuj
    Abbasi, Taher
    Mazumder, Amitabha
    [J]. BLOOD, 2013, 122 (21)
  • [8] An innovative patient-specific cholangiocarcinoma-on-chip as a platform for personalized therapy
    Polidoro, M. A.
    Saladino, G.
    Ferrari, E.
    Marzorati, S.
    Rasponi, M.
    Lleo, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S223 - S224
  • [9] Personalized Therapy for Acute Myeloid Leukemia
    Hourigan, Christopher S.
    Karp, Judith E.
    [J]. CANCER DISCOVERY, 2013, 3 (12) : 1336 - 1338
  • [10] Niche-like Ex Vivo High Throughput (NEXT) Drug Screening Platform in Acute Myeloid Leukemia
    Figueiras, Reinaldo Dal Bello
    Pasanisi, Justine
    Joudinaud, Romane
    Duchmann, Matthieu
    Sodaro, Gaetano
    Chauvel, Clementine
    Vasseur, Loic
    Pardieu, Bryann
    Ling, Frank
    Pacchiardi, Kim
    Vaganay, Camille
    Faivre, Lionel
    Benaksas, Chaima
    Preudhomme, Claude
    Raffoux, Emmanuel
    Clappier, Emmanuelle
    Ades, Lionel
    Puissant, Alexandre
    Itzykson, Raphael
    [J]. BLOOD, 2020, 136
12345